期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

乳腺癌抗肿瘤药物的心脏毒性 被引量：2

Cardiotoxicity associated with antineoplastic drugs in breast cancer
原文传递
导出
摘要 从临床表现、发生机制、危险因素、监测方法和预防与治疗等方面，对乳腺癌治疗常用化疗药物蒽环类药物和曲妥珠单抗的心脏毒性进行了论述。 Cardiotoxicity associated with anthracyclines and trastuzumab is discussed from clinical manifestations, pathogenesis, risk factors, monitoring methods, prevention and treatment.
作者 赵新 吴世凯 宋三泰
机构地区 军事医学科学院附属医院乳腺肿瘤内科
出处 《肿瘤研究与临床》 CAS 2011年第2期77-80,84,共5页 Cancer Research and Clinic
关键词 乳腺肿瘤 抗肿瘤联合化疗方案 蒽环类药物 曲妥珠单抗 心脏毒性 Breast neoplasms Antineoplastic combined chemotherapy protocols Anthracyclines Trastuzumab Cardiotoxicity
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献40

  • 1O'Shaughnessy J, Twelves C, Aapro M. Treatment for anthracycline-pretreated metastatic breast cancer. Oncologist, 2002, 7: 4-12.
  • 2Swain SM, Whaley FS, Ewer MS. Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials. Cancer, 2003, 97: 2869-2879.
  • 3Mercuro G, Cadeddu C, Piras A, et al. Early epirubicin-induced myocardial dysfunction revealed by serial tissue doppler echocardiography: correlation with inflammatory and oxidative stress markers. Oncologist, 2007, 12:1124-1133.
  • 4Jensen BV, Skovsgaard T, Nielsen SL. Functional monitoring of anthracycline cardiotoxicity: a prospective; blinded, long-term observational study of outcome in 120 patients. Ann Oncol, 2002, 13: 699-709.
  • 5Duquaine D, hirsch GA, Chakrabarti A, et al. Rapid-onset endothslial dysfunction with adriamycin: evidence for a dysfunctional nitric oxide synthase. Vase Med, 2003, 8: 101-107.
  • 6Li T, Singal PK. Adriamycin-induced early changes in myocardial.antioxidant enzymes and their modulation by prohucol. Circuiation, 2000, 102: 2105-2110.
  • 7Wang S, Konorev EA, Kotamraju S, et al. Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms, intermediacy of H(2)O(2)-and p53-dependent pathways. J Biol Chem, 2004, 279: 25535-25543.
  • 8Sawyer DB, Fukazaws R, Arstall MA,4: 257-265. et al. Daunorubicinduced apoptosis in rat cardinc myocytes is inhibited by dexrazoxane. Circ Res, 1999, 8.
  • 9Von Hoff I)D, Layard MW, Basa P, et al. Risk factors for doxorubicin- induced congestive heart failure. Ann Intern Med, 1979, 91: 710-717.
  • 10Bonadonna G, Gianni L, Santoro A, et al. Drugs ten years later: epirubicin. Ann Oncol, 1993, 4: 359-369.

同被引文献33

  • 1胡夕春,王佳蕾.曲妥珠单抗(赫赛汀)最新临床研究进展[J].临床药物治疗杂志,2004,2(6):45-51. 被引量：13
  • 2陈纯波,孙诚,吴粤.充血性心力衰竭患者血浆N-端脑利钠肽前体水平的变化[J].实用医学杂志,2005,21(11):1164-1165. 被引量：20
  • 3佟倩.联合放化疗对乳腺癌患者心脏毒性的临床观察[J].肿瘤研究与临床,2006,18(12):830-831. 被引量：7
  • 4Doust JA, Pietrzak E, Dobson A, et al. How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. BMJ, 2005, 330: 625.
  • 5Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health Conditions in adult survivors of childhood cancer. N Engl J Med, 2006, 355: 1572-1582.
  • 6Jemai A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin, 2006, 56: 106-130.
  • 7Erkus B, Demirtas S, Yarpuzlu AA, et al. Early prediction of artthracycline induced eardiotoxieity. Acta Paediatr, 2007, 96: 506- 509.
  • 8Iaarussi D, Galderisi M, Ratti G, et al. Left ventficular systolic and diastolic function after anthrathcline chemotherapy in childhood. Clin Cardiol, 2001, 24: 663-669.
  • 9Lobos-Bejarano JM, Horrillo-Garea C, Gonzalez AI, et al. Validity and usefulness of B-type natriuretic peptide (BNP) for early detection of left ventricular dysfunction in high-risk patients in primary care. Aten Primaria, 2012, 44: 13-19.
  • 10Karasek D, Sinkiewicz W, BIatejewski J. Relationship between B-type natriuretic peptide serum level echw, ardiographic TEl index and the degree of diastolic dysfunction in patients with heart failure with preserved systolic function. Arch Med Sci, 2011,7: 449-456.

引证文献2

二级引证文献17

肿瘤研究与临床
2011年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部